The incidence of injection drug use–associated infective endocarditis has been increasing
rapidly over the last decade. Patients with drug use–associated infective endocarditis …

Heart valve replacement has steadily increased over the past decades due to improved
surgical mortality, an aging population, and the increasing use of transcatheter valve …

The COVID-19 pandemic has triggered changes in the substance use disorder (SUD)
treatment delivery system, in the availability of legal and illicit drugs, and in other social and …

Recent studies have called attention to the rising rates of infective endocarditis (IE) in the
context of COVID-19 (Quintero-Martinez et al., 2022; Wang et al., 2022). Risk of infective …

Background Hospitalizations for infective endocarditis (IE) associated with opioid use
disorder (O-IE) have increased in the USA and have been linked to high rates of discharge …

Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective
endocarditis in patients with substance use disorder - Clinical Microbiology and Infection Skip to …

Objectives We conducted a pilot randomized controlled trial (RCT) to explore whether a
hospital inpatient addiction consult team (Substance Use Treatment and Recovery Team …

Background Hospital patients who use drugs may require prolonged parenteral
antimicrobial therapy administered through a vascular access device (VAD). Clinicians' …

Objectives Hospitalizations for drug use-associated infective endocarditis (DUA-IE) have
risen sharply across the United States over the past decade. The sex composition of DUA-IE …

Background: Infective endocarditis (IE) continues to be a disease with high mortality despite
medical advances. Objective: The objective of this study was to investigate the …